The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

The Wilkinson laboratory studies reverse transcriptases and retrotransposons using biochemistry, structural biology, and genome mining.

At the 12th International HIV Drug Resistance Workshop, held June 10-14, 2003, in Los Cabos, Mexico, investigators from around the world provided the latest results from studies of resistance topics ...

Activating lysosome biogenesis helps alleviate cellular senescence in progeria. Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic condition that causes rapid aging and a range of visible ...

HIV-1 reverse transcriptase inhibitors have long been central to antiretroviral therapy, effectively impeding the enzyme responsible for converting viral RNA into DNA – a pivotal step in HIV ...

The agreement gives Chiesi exclusive rights for the development and commercialisation of ABO-101 to treat PH1.

A research team in Japan has developed an innovative system that can accurately detect genetic mutations in brain tumors ...

Fast but less accurate "rapid antigen tests" now account for 60% of all coronavirus tests in India, the head of a top diagnostic firm estimated on Wednesday, warning that such a high use could ...